 |
|
India can achieve 10-11 p.c. GDP growth
MORE
[+] |
|
| |
| 03. INVESTMENT UPDATE |
 |

|
FAVOURABLE GLOBAL TRENDS FOR INDIAN PHARMACEUTICAL INDUSTRY
Indian pharmaceutical industry has carved out a unique place on the global map, not only as a manufacturer of generic drugs but also of new formulations, with growing emphasis on research and development and new drug discovery, says an Exim Bank study. With annual turnover of over US $ 11 billion, Indian pharmaceutical industry is globally ranked 4th, in terms of volume, with a share of 8% in world pharmaceutical market. |
|
 |
The global pharmaceutical market is characterised by greater levels of R&D expenditure and extensive regulation of its products. Although the developed countries dominate the global pharmaceutical market, the share of developing countries like India, China and Mexico has been increasing in recent years.
The study, analysing the evolution of Indian pharmaceutical industry, has observed that the transition period, provided under the TRIPS agreement of WTO, has been utilized effectively by Indian firms to undertake activities such as clinical research, new drug development and patent filing. New countries, such as Brazil, South Africa, Turkey and Ukraine, have emerged as important destinations for India. For many countries in Africa and South Asia, India is one of the principal source countries for pharmaceutical imports. However, India's share in pharmaceutical imports of developed country markets (such as USA, EU and Japan) is still low, though they are India's largest export destinations. |
Increasing R&D activities, Filing of Drug Master Files (DMF) and Abbreviated New Drug Applications (ANDA) with US-FDA; leveraging bio-technology; specialising in contract research, contract manufacturing and co-marketing alliances; diversification of markets; and inorganic growth through mergers and acquisitions are some of the success strategies adopted by the Indian pharmaceutical industry. However, there are also challenges, which need to be addressed by the Indian pharmaceutical industry.
Given the expertise and experience, Indian pharmaceutical industry should be in a position to garner a significant share in the world market. Some of the strategies prescribed by the study include strengthening R&D activities, market penetration in LDCs through acquisitions, stepping up of bio-pharma convergence, addressing safety and quality issues, emphasis on patent filings, skill development and tackling of patent infringement cases. |
|
|
|
|
INSURANCE OFFSHORING BUSINESS TO TOUCH $1BN BY 2010 |
Revenues from offshore insurance business process outsourcing (BPO) services in India are slated to touch $2 billion while the employee base of insurance BPO firms is expected to exceed one lakh by calendar 2010, notes a recent KPMG publication.“The sector currently has 41,600 people on its payrolls and generates an estimated revenue of $790 million,” KPMG global head of sourcing advisory Pradeep Udhas told ET. Traditionally, insurance companies have been among the slowest to adopt outsourcing/ offshoring. But in the past few years, market dynamics have changed as a result of shrinking margins, higher claims disbursement and increasing competition, especially since September 11, 2001. India is likely to be one of the major beneficiaries.
According to the KPMG publication, christened ‘Frontiers in finance: Financial services for decision makers in financial services’, a large number of Indian vendors are expected to evolve into mature, end-to-end service providers, competing with multinational outsourcing companies by 2010. Currently, players like Aviva, Prudential Inc and AXA are among the larger players operating in India. “However, players like Genpact, WNS and EXL Services, as well as BPO offshoots of IT companies such as IBM, TCS, Infosys (Progeon) and Wipro are expected to emerge as competitive global players in the segment,” KPMG India executive director Sanjay Aggarwal said.
As insurance services mature and more high-end processes like analytics, actuarial and underwriting services move to India, the BPO industry is expected to grow further, the study suggests. “Another growth area is claims and policy administration. Providers include large, mid-size and small service companies. The larger BPO companies are likely to continue dominating the landscape in the next two to three years,” said Mr Aggarwal.
|
The size of the US insurance industry, with over 1,500 property and casualty insurance companies and 1,300 health cover entities in the US alone, makes insurance outsourcing an attractive market. To cash in on the growth potential, several niche providers with relevant expertise are investing and encouraging insurance companies to outsource more value-added services.
Some of the key drivers of insurance offshoring are stringent insurance regulation and statutory documentation in the US along with deregulation of insurance markets in America.“This is prompting health maintenance organisations to move their processes offshore which has tallied with availability of credible service providers. Moreover, insurers in the US are looking at minimising risk through multiple delivery locations,” Mr Aggarwal said.
KPMG also suggested that India offers several benefits as a leading insurance outsourcing destination. These includes low cost advantage, established destination for outsourcing, Indian companies offer near-shore services. Though growth is constant in the insurance industry, insurers are expected to consistently deliver double-digit revenue growth to become or remain a major player.
“Mergers and acquisitions, geographic expansion, product development, cross-selling and client retention are all vital strategies. Insurers are expanding into emerging markets such as Central and Eastern Europe, Russia and India, which are generally underinsured but increasingly affluent,” KPMG said. According to the report, insurance outsourcing was likely to touch $790 million this year from an estimated $367 million in 2003, at an annual growth rate of 21%. Going ahead, there would be more business out of Europe, which is likely to increase from the present 24% to 36% by 2010, it added.
|
|
INDIA’S DIRECT INVESTMENT ABROAD INCREASES 80% IN 2006-07 |
The massive surge in investment by foreign institutional investors (FII) after the Fed rate cut has prompted RBI to propose further liberalisation in norms of foreign investment by Indian companies, residents and mutual funds (ET, September 25). FII inflows stood at a staggering $1.5 billion and the Central bank proposed to increase outward investment to control liquidity and rein in rupee.
Source : The Economic Times |
LOUIS TO MAKE $500-600 MN INVESTMENT IN INDIA |
Global luxury brands conglomerate Louis Vuitton Moet Hennessy (LVMH) is planning to launch a $500-600 million private equity fund in India for investing in brands and retail chains.
LVMH President (South, South-East and West Asia operations) Ravi Thakran said that the group is also looking for a foray into luxury destinations such as spas and entertainment for which it was in talks with real estate developers, including major DLF, to acquire land.
"We are planning to make private equity investments of $500-600 million in Indian retail chains and brands," he said, adding the fund would be launched by L Capital Partners, of LVMH, within 12 months.
Besides looking for new ventures, LVMH is strengthening its existing business with plans to open 25 new outlets across the country, he added.
The luxury goods giant, which has brands like Christian Dior, Fendi, TAG Heuer and Dom Perignon, is also gearing up to launch luxury brands like Kenzo, Marc Jacobs, Berluti, couture brands Givenchy, Loewe, Celine and Pucci by 2008.
Mittal to invest US$ 20 billion in steel plants in India
Source : The Economic Times |
|
|
|
|
|
|
|